jennifer zinn

About jennifer zinn

Jennifer Zinn is currently Executive Vice President, Clinical Operations at bioMérieux, the global in vitro diagnostics company. She joined the group on October 31, 2022 as General Manager and Head of Clinical Operations – North America, and was then appointed to lead global Clinical Operations effective August 1, 2023. As a member of the Executive Committee, she reports directly to the Chief Executive Officer and oversees bioMérieux’s worldwide clinical commercial organization, alongside several global functions linked to commercial performance, customer service, distribution channel management, and health data insights. In practice, this places her at the center of the company’s operational execution and market-facing strategy. One of her early responsibilities was helping prepare the U.S. launch of BIOFIRE® SPOTFIRE®, bioMérieux’s multiplex PCR system designed for decentralized point-of-care settings. Zinn brings nearly 30 years of healthcare experience, including about 20 years in the diagnostics industry. Before joining bioMérieux, she served as Executive Vice President and Head of Diagnostics, North America at Siemens Healthineers from 2019 onward. Prior to that, she spent nine years at Roche Diagnostics, where she led commercial operations for North America, including Point of Care and non-hospital diagnostics. She also worked for six years at Ortho Clinical Diagnostics in commercial operations roles. Her background reflects strong expertise in commercial strategy, market development, organizational leadership, and the scaling of diagnostic portfolios across large healthcare markets. Beyond her corporate roles, she has served on several boards, including the AdvaMedDx Board, and has contributed to the Gold Foundation Corporate Council. At bioMérieux, she is closely associated with strategic initiatives around antimicrobial resistance, broader access to diagnostics, and the advancement of clinically relevant innovation worldwide.